Научные статьи \ Математика. Естественные науки \ Биологические науки в целом \ Материальные основы жизни. Биохимия. Молекулярная биология. Биофизика

УСТРОЙСТВА POINT-OF-CARE (POC): КЛАССИФИКАЦИЯ И ОСНОВНЫЕ ТРЕБОВАНИЯ

УСТРОЙСТВА POINT-OF-CARE (POC): КЛАССИФИКАЦИЯ И ОСНОВНЫЕ ТРЕБОВАНИЯ

Автор: А. Н. Зубик, Г. Е. Рудницкая, А. А. Евстрапов, Т. А. Лукашенко

Журнал: Научное приборостроение @nauchnoe-priborostroenie

Рубрика: Обзоры

Статья в выпуске: 3 т.32, 2022 года.

Бесплатный доступ

В обзоре представлена классификация устройств point-of-care (POC), обсуждены основные характеристики устройств и требования, предъявляемые к ним. Рассмотрены различия между методом POC-тестирования и лабораторным методом анализа. Приведены примеры устройств, подходящих под определение POC для диагностики инфекционных заболеваний.

Point-of-care (POC), lab-on-chip (LOC), lab-on-а-disc (LOAD), микрофлюидика, микрофлюидный чип, тест-полоска, тест-полоска латерального потока (LFA), микрофлюидное бумажное аналитическое устройство (μPAD)

Короткий адрес: https://sciup.org/142234688

IDR: 142234688   |   УДК: 577.2.08   |   DOI: 10.18358/np-32-3-i329

POINT-OF-CARE (POC) DEVICES: CLASSIFICATION AND BASIC REQUIREMENTS

The review presents the classification of point-of-care (POC) devices, and discusses the main characteristics of the devices and the requirements for them. The differences between the POC testing method and the laboratory method of analysis are considered. Examples of devices that fit the definition of POC for diagnosing infectious diseases are given.

Список литературы УСТРОЙСТВА POINT-OF-CARE (POC): КЛАССИФИКАЦИЯ И ОСНОВНЫЕ ТРЕБОВАНИЯ

  • 1. Kumar S., Nehra M., Khurana S., et al. Aspects of pointof-care diagnostics for personalized health wellness // Int. J. Nanomedicine. 2021. Vol. 16. P. 383–402. DOI: 10.2147/IJN.S267212
  • 2. Liu D., Wang Y., Li X., et al. Integrated microfluidic devices for in vitro diagnostics at point of care // Aggregate. 2022. e184. DOI: 10.1002/agt2.184
  • 3. Pandey C.M., Augustine S., Kumar S., et al. Microfluidics based point-of-care diagnostics // Biotechnol. J. 2018. Vol. 13, is. 1. Id. 1700047. DOI: 10.1002/biot.201700047
  • 4. Xiguang L., Xiangzhi Z., Gerald K.J., et al. The creation of point-of-careology // Point of Care: The Journal of Near-Patient Testing & Technology. 2019. Vol. 18, № 3. Р. 77–84. DOI: 10.1097/POC.0000000000000191
  • 5. Wang C., Liu M., Wang Z., et al. Point-of-care diagnostics for infectious diseases: From methods to devices // Nano Today. 2021. Vol. 37. Id. 101092. DOI: 10.1016/j.nantod.2021.101092
  • 6. Liu Y., Zhan L., Qin Z., et al. Ultrasensitive and highly specific lateral flow assays for point-of-care diagnosis // ACS Nano. 2021. Vol. 15, № 3. P. 3593−3611. DOI: 10.1021/acsnano.0c10035
  • 7. Majdinasab M., Badea M., Marty J.L. Aptamer-based lateral flow assays: Current trends in clinical diagnostic rapid tests // Pharmaceuticals. 2022. Vol. 15, № 1. DOI: 10.3390/ph15010090
  • 8. Pohanka M. Point-of-care diagnoses and assays based on lateral flow test // Int. J. Anal. Chem. 2021. Vol. 2021. ID 6685619. DOI: 10.1155/2021/6685619
  • 9. Сафронова В.А., Самсонова Ж.В., Григоренко В.Г., Осипов А.П. Определение прогестерона методом латерального проточного иммуноанализа // Вестн. Моск. Ун-та. Сер. 2. Химия. 2012. Т. 53, № 5. C. 326–334. URL: https://www.elibrary.ru/item.asp?id=18751263
  • 10. Nguyen N.N.T., McCarthy C., Lantigua D., CamciUnal G. Development of diagnostic tests for detection of SARS-CoV-2 // Diagnostics. 2020. Vol. 10, № 11. Id. 905. DOI: 10.3390/diagnostics10110905
  • 11. Carbon Valley Farmer and Miner: Lateral flow assay market size volume, share, demand growth, business opportunity by 2030. [Электронный ресурс]. 2022. URL:
  • http://www.cvfarmerandminer.com/content/lateral-flowassay-market-size-volume-share-demand-growthbusiness-opportunity-by-2030 (дата обращения: 01.07.2022).
  • 12. www.biovendor.cz/userfiles/microsites/genexpert/tri%20v%20rade.png (дата обращения 01.07.2022).
  • 13. Cambridge Consultants. Final Report: Cost of goods and manufacturing analysis of GeneXpert cartridges. [Электронный ресурс]. 2019. 37 p. URL: https://msfaccess.org/sites/default/files/201912/2018%20COGS%20analysis%20of%20Xpert%20MTB_RIF%20Ultra%20cartridges.pdf (дата обращения: 01.07.2022).
  • 14. Gotham D., McKenna L., Deborggraeve S., Madoori S., Branigan D. Public investments in the development of GeneXpert molecular diagnostic technology // PLoS ONE. 2021. DOI: 10.1371/journal.pone.0256883
  • 15. Xpert® Xpress SARS-CoV-2: Инструкция по применению. [Электронный ресурс]. Cepheid, 2021. 28 p. URL:
  • https://www.cepheid.com/Package%20Insert%20Files/Xpress-SARS-CoV-2/Xpert%20Xpress%20SARS-CoV2%20Assay%20RUSSIAN%20Package%20Insert%20302-3787-RU-RU%20Rev.%20B.pdf (дата обращения: 01.07.2022).
  • 16. Niemz A., Ferguson T.M., Boyle D.S. Point-of-care nucleic acid testing for infectious diseases // Trends. Biotechnol. 2011. Vol. 29, is. 5. P. 240–250. DOI: 10.1016/j.tibtech.2011.01.007
  • 17. Biomerieux. URL: www.biomerieux-russia.com (дата обращения: 01.07.2022).
  • 18. Poritz M.A., Blaschke A.J., Byington C.L., et al. FilmArray, an automated nested multiplex PCR system for multipathogen detection: development and application to respiratory tract infection. // PLoS One. 2011. Vol. 6, no. 11. DOI: 10.1371/journal.pone.0026047
  • 19. Seiner D.R., Colburn H.A., Baird C., et al. Evaluation of the FilmArray® system for detection of Bacillus anthracis, Francisella tularensis and Yersinia pestis // J. Appl. Microbiol. 2013. Vol. 114, is. 4. Р. 992–1000. DOI: 10.1111/jam.12107
  • 20. Dailey P.J., Osborn J. Landscape of molecular platforms for near-patient testing: the MAPDx Program [Электронный ресурс]. Geneva: FIND, 2019. 36 p. URL: https://www.finddx.org/wpcontent/uploads/2019/08/Public_Molecular-LandscapeReport_FINAL-Aug2019docx.pdf (дата обращения: 01.07.2022).
  • 21. Tuberculosis diagnostics technology and market landscape. Technical report. 4th edition. Switzerland: World Health Organization, 2015. 88 c.
  • 22. The next generation in molecular diagnostics. URL: https://tangenbiosciences.com/ (дата обращения: 01.07.2022).
  • 23. Морозова К. Лаборатория на диске: Tangen разрабатывает новый метод диагностики. [Электронный ресурс] PCR.news [сайт], 2019. URL: https://pcr.news/novosti/laboratoriya-na-diske-tangenrazrabatyvaet-novyy-metoddiagnostiki/?ysclid=l4y86hmnip924385457 (дата обращения: 01.07.2022).
  • 24. Tangen Biosciences [Электронный ресурс]. URL: www.cbinsights.com/company/tangen-biosciences (дата обращения: 01.07.2022).
  • 25. LabWare Portable Disease Surveillance Lab (PDSL): Fighting COVID-19 and Reducing Turnaround Time for Test Results [Электронный ресурс]. URL: www.labware.com/lims/portable-disease-surveillance-lab (дата обращения: 01.07.2022).
  • 26. Stedtfeld R.D., Tourlousse D.M., Seyrig G., et al. Gene-Z: a device for point of care genetic testing using a smartphone // Lab. Chip. 2012. Vol. 12, no. 8. P. 1454–1462. DOI: 10.1039/c2lc21226a
  • 27. Zhang W., Guo S., Carvalho W.S.P., et al. Portable pointof-care diagnostic devices // Anal. Methods. 2016. Vol. 8. P. 7847–7867. DOI: 10.1039/c6ay02158a
  • 28. Pai N.P., Vadnais C., Denkinger C., et al. Point-of-care testing for infectious diseases: diversity, complexity, and barriers in low- and middle-income countries // PLoS Med. 2012. Vol. 9, no. 9. e1001306. DOI: 10.1371/journal.pmed.1001306
  • 29. Kettler H., White K., Hawkes S. Mapping the landscape of diagnostics for sexually transmitted infections. [Электронный ресурс]. TDR World Health Organ, 2004. 44 p. URL: https://apps.who.int/iris/bitstream/handle/10665/68990/TDR_STI_IDE_04.1.pdf (дата обращения: 01.07.2022).
  • 30. Hsieh Y.-H., Gaydos C.A., Hogan M.T., et al. What qualities are most important to making a point of care test desirable for clinicians and others offering sexually transmitted infection testing? // PLoS One. 2011. Vol. 6, is. 4. e19263. DOI: 10.1371/journal.pone.0019263
  • 31. Land K.J., Boeras D.I., Chen X.-S., et al. REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes // Nat. Microbiol. 2019. Vol. 4. Р. 46–54. DOI: 10.1038/s41564-018-0295-3
  • 32. Wu G., Zaman M.H. Low-cost tools for diagnosing and monitoring HIV infection in low-resource settings // Bull. World Health Organ. 2012. Vol. 90, № 12. P. 914–920. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3524957/
  • 33. Lofgren S.M., Morrissey A.B., Chevallier C.C., et al. Evaluation of a dried blood spot HIV-1 RNA program for early infant diagnosis and viral load monitoring at rural and remote healthcare facilities // AIDS. 2009. Vol. 23, is. 18. P. 2459–2466. DOI: 10.1097/QAD.0b013e328331f702
  • 34. Mabey D., Peeling R., Ustianowski A., et al. Diagnostics for the developing world // Nat. Rev. Microbiol. 2004. Vol. 2. P. 231–240. DOI: 10.1038/nrmicro841
  • 35. Mauk M.G., Song J., Liu C., Bau H.H. Simple approaches to minimally-instrumented, microfluidic-based point-ofcare nucleic acid amplification tests // Biosensors. 2018. Vol. 8, is. 1. DOI: 10.3390/bios8010017
  • 36. Primiceri E., Chiriacò M.S., Notarangelo F.M., et al. Key enabling technologies for point-of-care diagnostics // Sensors. 2018. Vol. 18, is. 11. DOI: 10.3390/s18113607
  • 37. Manocha A., Bhargava S. Emerging challenges in pointof-care testing // Сurr. Med. Res. Pract. 2019. Vol. 9, is. 6. P. 227–230. DOI: 10.1016/j.cmrp.2019.11.006
  • 38. Malekjahani A., Sindhwani S., Syed A.M., Chan W.C.W. Engineering steps for mobile point-of-care diagnostic devices // Acc. Chem. Res. 2019. Vol. 52, is. 9. P. 2406–2414. DOI: 10.1021/acs.accounts.9b00200
  • 39. Wang P., Kricka L.J. Current and emerging trends in point-of-care technology and strategies for clinical validation and implementation // Clin. Chem. 2018. Vol. 64, is. 10. P. 1439–1452. DOI: 10.1373/clinchem.2018.287052
  • 40. Sachdeva S., Davis R.W., Saha A.K. Microfluidic pointof-care testing: commercial landscape and future directions // Front. Bioeng. Biotechnol. 2021. DOI: 10.3389/fbioe.2020.602659
  • 41. Mielczarek W.S., Obaje E.A., Bachmann T.T., KersaudyKerhoas M. Microfluidic blood plasma separation for medical diagnostics: is it worth it? // Lab. Chip. 2016. Is. 18. P. 3441–3448. DOI: 10.1039/c6lc00833j
  • 42. Mark D., Haeberle S., Roth G., et al. Microfluidic lab-ona-chip platforms: requirements, characteristics and applications // Chem. Soc. Rev. 2010. Vol. 39, is. 3. P. 1153–1182. DOI: 10.1039/b820557b
  • 43. Martinez A.W., Phillips S.T., Butte M.J., Whitesides G.M. Patterned paper as a platform for inexpensive, lowvolume, portable bioassays // Angew. Chem., Int. Ed. Engl. 2007. Vol. 46, is. 8. P. 1318–1320. DOI: 10.1002/anie.200603817
  • 44. Miyazaki C.M., Carthy E., Kinahan D.J. Biosensing on the centrifugal microfluidic Lab-on-a-Disc platform // Processes. 2020. Vol. 8, is. 11. DOI: 10.3390/pr8111360
  • 45. Smith S., Mager D., Perebikovsky A., et al. CD-based microfluidics for primary care in extreme point-of-care settings // Micromachines. 2016. Vol. 7, is. 2. DOI: 10.3390/mi7020022
  • 46. Knowledge center. URL: www.sightdx.com/knowledgecenter/point-of-care-testing (дата обращения: 01.07.2022).
  • 47. Дементьева Н.И., Морозов Ю.А., Чарная М.А., Гончарова А.В. Технологии Point of care в клинике неотложных состояний // Клиническая лабораторная диагностика. 2013. № 7. С. 5–10. URL: https://www.elibrary.ru/item.asp?id=20253920
  • 48. Harpaldas H., Arumugam S., Campillo Rodriguez C., et al. Point-of-care diagnostics: recent developments in a pandemic age // Lab. Chip. 2021. Vol. 21, is. 23. P. 4517–4548. DOI: 10.1039/d1lc00627d
  • 49. Syedmoradi L., Norton M.L., Omidfar K. Point-of-care cancer diagnostic devices: From academic research to clinical translation // Talanta. 2021. Vol. 225. DOI: 10.1016/j.talanta.2020.122002
  • 50. Makower J., Meer A., Denend L. FDA impact on U.S. medical technology innovation: a survey of over 200 medical technology companies [Электронный ресурс]. PricewaterhouseCoopers LLP, 2010. 44 p. URL: https://www.medtecheurope.org/wpcontent/uploads/2015/07/01112010_FDA-impact-on-USmedical-technology-innovation_Backgrounder.pdf (дата обращения: 01.07.2022).
  • 51. Zarei M. Advances in point-of-care technologies for molecular diagnostics // Biosens. Bioelectron. 2017. Vol. 98. P. 494–506. DOI: 10.1016/j.bios.2017.07.024
Еще
QR-код для установки приложения SciUp Наведите камеру и скачайте бесплатное приложение SciUp